This inventor holds 4 USPTO granted patents. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 1998-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2000
Title: Kei Okazaki: Innovator in Imidazole Derivatives
Introduction
Kei Okazaki is a notable inventor based in Nogi-machi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of imidazole derivatives. With a total of 4 patents to his name, Okazaki's work has the potential to impact various therapeutic areas.
Latest Patents
One of Okazaki's latest patents focuses on imidazole derivatives and the process for preparing them. This invention relates to selective antagonistic substances against muscarinic acetylcholine. The patent provides imidazole derivatives represented by a general formula, where various substituents and groups are defined, showcasing the complexity and potential applications of these compounds.
Career Highlights
Kei Okazaki is currently employed at Kyorin Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to advancing medicinal chemistry and developing new therapeutic agents.
Collaborations
Throughout his career, Okazaki has collaborated with esteemed colleagues such as Yasuo Takano and Takashi Hirayama. These collaborations have likely enriched his research and contributed to the successful development of his patents.
Conclusion
Kei Okazaki is a prominent figure in the field of pharmaceutical innovation, particularly known for his work on imidazole derivatives. His contributions through patents and collaborations highlight his dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile